Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Symphonix submits hearing devices for US approval:

This article was originally published in Clinica

Executive Summary

Symphonix Devices has submitted a premarket approval application to the US FDA for its semi-implantable devices for treating sensorineural hearing loss. The Vibrant P and Vibrant D soundbridges use an external audio processor and an implantable floating mass transducer, the size of a grain of rice, to convert acoustic sound to vibrations inside the middle ear. Since no portion of the device sits in the ear canal, problems associated with a traditional hearing aid, such as occlusion, feedback and external ear infections are potentially eliminated, said the San Jose, California-based company.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT079464

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel